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Introduction {#onco13299-sec-0001}
============

China and the rest of the world are experiencing an outbreak of the 2019 novel coronavirus disease (COVID‐19). By February 22, 2020, the rapid spread of the virus had caused 77,041 infections and 2,445 deaths in China, and emerging cases have been reported in more than 30 countries, including the U.S., Japan, and South Korea. More than two thirds of cases and deaths from the infection occurred in Wuhan, China. On January 31, 2020, the World Health Organization declared COVID‐19, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a public health emergency of international concern.

Patients with cancer are more susceptible to viral infection than healthy individuals because of their systemic immunosuppressive status caused by the malignancy and anticancer treatments, such as surgery or chemotherapy; therefore, these patients might be at increased risk for COVID‐19 and have a poorer prognosis [1](#onco13299-bib-0001){ref-type="ref"}.

As one of the largest medical centers in Wuhan, ground zero of the outbreak, our hospital encountered patients with COVID‐19 with various medical conditions. Here, we report the results of a retrospective review of medical records from three women diagnosed with COVID‐19 after gynecologic surgery in our Gynecologic Oncology ward in January 2020; each had met the diagnostic criteria of the New Coronavirus Pneumonia Prevention and Control Program (6th edition), published by the National Health Commission of China [2](#onco13299-bib-0002){ref-type="ref"}.

Results {#onco13299-sec-0002}
=======

From January 1, 2020, to January 31, 2020, three women were postoperatively diagnosed with COVID‐19 in our Gynecologic Oncology ward (Union Hospital, Tongji Medical College, Huazhong University of Science and Technology). The incidence of COVID‐19 was 0.77% (3 of 389) of the total hospitalizations and 1.59% (3 of 189) among the patients undergoing surgeries in the ward and hospitalized during the same time period. There were no COVID‐19 diagnoses in the 200 patients without surgery. Among the 189 patients with gynecologic tumors who had received surgery, COVID‐19 occurred predominantly in those with malignant diseases, with comorbidities (hypertension, diabetes, and cardiovascular disease), aged \>45 years, and with postoperative fever persisting for 3 days or longer (Table [1](#onco13299-tbl-0001){ref-type="table"}).

###### 

The incidence of COVID‐19 in different subgroups of patients hospitalized after gynecologic oncology surgery

                                                          *n*   COVID‐19, *n* (%)   *p* value[a](#onco13299-note-0003){ref-type="fn"}
  ------------------------------------------------------- ----- ------------------- ---------------------------------------------------
  Tumor type                                                                        
  Malignant                                               33    2 (6.1)             .0236
  Benign                                                  156   1 (0.6)             
  Comorbidities[b](#onco13299-note-0004){ref-type="fn"}                             
  Yes                                                     40    3 (7.5)             .0075
  No                                                      149   0                   
  Age, year                                                                         
  \>45                                                    69    3 (4.3)             .0213
  ≤45                                                     120   0                   
  Fever ≥3 days                                                                     
  Yes                                                     9     3 (33.3)            \<.0001
  No                                                      180   0                   

Fisher\'s exact test.

Hypertension, diabetes, and cardiovascular disease.

The detailed clinical features and disease courses of the three COVID‐19 cases are summarized in Table [2](#onco13299-tbl-0002){ref-type="table"}. The three patients did not report any direct contact with infected individuals, and their x‐rays and computed tomography (CT) scans of the chest did not show any abnormality preoperatively. The patients developed fever within 2 days after surgery, which persisted (highest temperatures of 38.7°C--39.4°C) despite the administration of anti‐inflammatory drugs (cephalosporin, meropenem, and moxifloxacin). One patient had a cough and significantly decreased blood oxygen. Positive CT findings showed signs of a viral pneumonia approximately 10 days after surgery in all three patients (Fig. [1](#onco13299-fig-0001){ref-type="fig"}), whereas two of them had a negative chest x‐ray or CT on days 4--6 postoperatively. All patients had negative results from tests of blood and throat swab samples for seven common respiratory pathogens, including respiratory syncytial virus, adenovirus, mycoplasma pneumoniae, chlamydia pneumoniae, coxsackievirus group B, the influenza B virus, and the influenza A virus. Finally, the viral DNA of SARS‐CoV‐2 was detected in the throat swab samples from the patients by using assays based on the real‐time reverse transcriptase polymerase chain reaction technique.

###### 

Clinical features of the three women diagnosed with COVID‐19 after gynecological oncology surgery

  Feature                                                                                   Case 1                              Case 2                                            Case 3
  ----------------------------------------------------------------------------------------- ----------------------------------- ------------------------------------------------- ----------------------------------------
  Age, years                                                                                47                                  48                                                59
  Residence                                                                                 Wuhan                               Huanggang (90 km from Wuhan)                      Zhumadian (260 km from Wuhan)
  Comorbidities                                                                             Diabetes and hypertension           Diabetes and hypertension                         Hypertension
  Known contact history[a](#onco13299-note-0005){ref-type="fn"}                             No                                  No                                                No
  Preoperative chest imaging[b](#onco13299-note-0006){ref-type="fn"}                        X‐ray (−)                           X‐ray (−), CT (−)                                 X‐ray (−)
  Gynecologic condition                                                                     Endometrial atypical hyperplasia    Squamous cervical cancer, stage I B1              Epithelial ovarian cancer, stage III C
  Surgery                                                                                   Hysterectomy                        Radical hysterectomy                              Cytoreductive surgery
  Timing of fever onset (days after hospitalization)                                        5 days                              9 days                                            5 days
  Timing of fever onset (days after surgery)                                                1 day                               2 days                                            1 days
  Fever peak                                                                                39.4°C                              38.8°C                                            38.7°C
  Cough                                                                                     Yes                                 No                                                No
  Shortness of breath or fatigue                                                            No                                  No                                                No
  Lowest SpO2                                                                               90%                                 97%                                               98%
  Postoperative chest imaging, days after surgery[b](#onco13299-note-0006){ref-type="fn"}   X‐ray (−), 6 days; CT (+), 9 days   CT (+), 10 days                                   CT (−), 4 days; CT (+), 10 days
  White blood cells                                                                         6.57 g/L                            3.96 g/L                                          2.97 g/L
  Lymphocytes                                                                               0.53 g/L                            0.85 g/L                                          0.67 g/L
  CRP                                                                                       37.50 mg/L                          36.36 mg/L                                        9.44 mg/L
  ESR                                                                                       81 mm/h                             57 mm/h                                           NA
  D‐dimer                                                                                   1.16 ng/mL                          9.41 ng/mL                                        12.49 ng/mL
  Procalcitonin                                                                             \<0.13 μg/L                         \<0.13 μg/L                                       0.28 μg/L
  SARS‐CoV‐2                                                                                Positive                            Positive                                          Positive
  Blood culture for bacteria                                                                Negative                            Negative                                          Negative
  AST                                                                                       38 U/L                              192 U/L[c](#onco13299-note-0007){ref-type="fn"}   27 U/L
  ALT                                                                                       29 U/L                              106 U/L[c](#onco13299-note-0007){ref-type="fn"}   20 U/L
  Prognosis by Feb. 20                                                                      Discharged                          Discharged                                        In hospital

History of direct contact with other individuals infected with SARS‐CoV‐2.

(−), no signs of a viral pneumonia; (+), images of viral pneumonia.

This patient had undergone chemotherapy for three cycles before surgery. The elevated AST and ALT may be caused by the drugs.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C‐reactive protein; CT, computed tomography; ESR, erythrocyte sedimentation rate; NA, Not applicable; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; SpO2, peripheral oxygen saturation.

![Representative chest computed tomography images of COVID‐19 in three women after gynecologic surgery: multiple regions of patchy consolidation and ground‐glass opacities in bilateral lungs, coupled with scattered lesions along the bronchial bundles or the subpleural lungs.](ONCO-25-e982-g001){#onco13299-fig-0001}

The patients were transferred to a quarantine hospital and treated with antiviral drugs (oseltamivir or umifenovir) combined with supportive care. As of February 20, 2020, two of the three patients had been discharged from the hospital because they had met the discharge criteria (i.e., they had neither fever nor cough for at least 3 days, the lesions of lung had become much smaller according to chest CT imaging, and repeated negative results had been obtained in at least two consecutive viral DNA tests on different days [2](#onco13299-bib-0002){ref-type="ref"}); at this writing, the third patient was still being treated at the quarantine hospital.

Discussion {#onco13299-sec-0003}
==========

In previous studies, nearly half of patients with COVID‐19 had underlying chronic diseases, such as diabetes, hypertension, and cardiovascular disease, and the common symptoms at onset of illness included fever, cough, shortness of breath, and fatigue. Most patients had lymphopenia, and nearly all patients had pneumonia with abnormal findings on chest CT. Some patients developed acute respiratory distress syndrome, and some of these patients worsened in a short period of time and died of multiple organ failure [3](#onco13299-bib-0003){ref-type="ref"}, [4](#onco13299-bib-0004){ref-type="ref"}. Generally, the incubation period for COVID‐19 can last 2 weeks, or longer [2](#onco13299-bib-0002){ref-type="ref"}, [5](#onco13299-bib-0005){ref-type="ref"} considering that CT scan rather than x‐ray of the chest plays an essential role in the diagnosis of COVID‐19 and that the viral detection assays are not always available or accurate [6](#onco13299-bib-0006){ref-type="ref"}. In the epidemic area, it would be helpful to use CT scans to screen patients preoperatively. For patients with persisting fever after surgery, a lung CT scan needs to be done in a timely manner.

Data suggest that men are more susceptible than women, but in fact all populations are susceptible, including women [2](#onco13299-bib-0002){ref-type="ref"}, [3](#onco13299-bib-0003){ref-type="ref"}. Some studies reported that, with the rapid spread of the disease, many COVID‐19 diagnoses were made in people who had not had direct contact with other individuals infected with SARS‐CoV‐19 [7](#onco13299-bib-0007){ref-type="ref"}. In the current study, only one of three affected persons was from metropolitan Wuhan, and the others were from nearby. In an epidemic area of COVID‐19, more intensive surveillance for SARS‐CoV‐2 should be done before surgery. After surgery, if a patient\'s fever lasts for more than 3 days or is accompanied by respiratory symptoms, then COVID‐19 testing should be performed, even if the patient has had no contact with other verified cases. In the present case report, the patients were older than the average age of the patients in the ward during the same time period, suggesting that age also may be a risk factor for COVID‐19 after gynecologic tumor surgery. It was also observed, in all three cases, that the white blood cell count was not high and the lymphocyte count was reduced. One important finding was that there were no COVID‐19 diagnoses in the no‐surgery group, including 200 hospitalizations. It is suggested that only emergency gynecologic operations should be scheduled in an epidemic area.

Conclusion {#onco13299-sec-0004}
==========

We found that patients undergoing gynecological surgery were at risk for clinical manifestations of COVID‐19 after surgery in a gynecologic oncology ward. Postponement of scheduled gynecologic surgery for patients in the epidemic area is important and should be considered. More intensive surveillance for SARS‐CoV‐2 should be considered for patients undergoing gynecologic surgery, especially for patients with fever for more than 3 days, older patients, and patients with comorbidities.
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